Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03001609 Org: User:
Start: 11/30/16 End: 09/30/17 Due: 09/30/18

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03856697 Org: User:
Start: 03/31/19 End: 03/31/24 Due: 03/31/25

Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03300115 Org: User:
Start: 05/18/17 End: 12/17/20 Due: 12/17/21

A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL

Phase: N/A Priority: Normal
NCT ID: NCT03060850 Org: User:
Start: 03/17/17 End: 12/14/20 Due: 12/14/21

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02330367 Org: User:
Start: 01/31/15 End: 03/31/23 Due: 03/31/24

Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03053219 Org: User:
Start: 11/30/16 End: 12/31/18 Due: 12/31/19

A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI

Phase: N/A Priority: Normal
NCT ID: NCT03058094 Org: User:
Start: 12/31/18 End: 01/31/20 Due: 01/31/21